INTRODUCTION {#s1}
============

Development of complex tissues from naïve primordia requires the precise spatiotemporal deployment of transcriptional programs as cells subdivide, specify and differentiate. Owing to the availability of tissue- and cell type-specific markers characteristic for neurogenic cell types in the fruit fly embryo ([@DEV175265C20]), *Drosophila* neurogenesis is highly tractable and several crucial regulators of neurogenesis have been identified over the past several decades ([@DEV175265C46]; [@DEV175265C1]; [@DEV175265C7]; [@DEV175265C29]; [@DEV175265C40]; [@DEV175265C55]; [@DEV175265C16]; [@DEV175265C20]; [@DEV175265C47]; [@DEV175265C53]; [@DEV175265C56]). Among the earliest events in embryonic neurogenesis is the subdivision of the lateral neurogenic ectoderm into columnar domains along the dorsoventral axis ([@DEV175265C52]; [@DEV175265C12]). This is followed by the formation of proneural clusters and consecutive phases of delamination, whereby neuroblasts cease contact with surrounding cells of the neuroectodermal columns and ingress into the embryo ([@DEV175265C9]). Embryonic neuroblasts -- *Drosophila* neural stem cells -- undergo a series of self-renewing asymmetric divisions that produce ganglion mother cells, which give rise to glia and neurons ([@DEV175265C7]; [@DEV175265C48]; [@DEV175265C21]; [@DEV175265C20]). Importantly, each of the three neurogenic columns gives rise to molecularly and functionally distinct sets of neuroblasts ([@DEV175265C15]), but the molecular mechanisms that link spatial origin to the ensuing distinct fates remain poorly understood. To date, a small set of marker genes specifically expressed in individual columnar domains and in emerging cell types has been identified, but it remains unclear how these cell populations differ with respect to the global gene expression programs that shape their identities.

Although expression dynamics of protein-coding transcripts have given important insights into the mechanisms that drive cellular differentiation, it should be noted that an emerging class of noncoding transcripts -- the long noncoding RNAs (lncRNAs) -- may well emerge as pivotal regulators of neurogenesis. In mammals, lncRNAs have been shown to be especially abundant in differentiated neuronal cells ([@DEV175265C6]), are expressed often with exquisite spatiotemporal specificity in the nervous system ([@DEV175265C44]; [@DEV175265C17]), and some lncRNA species even exhibit neuronal subtype specificity ([@DEV175265C37]; [@DEV175265C34]). Though the functional importance of some lncRNAs for development and cellular identity has been demonstrated in *Drosophila* ([@DEV175265C54]), including in the nervous system ([@DEV175265C32]; [@DEV175265C30]), very little is known about the cell type-specific expression and function of lncRNAs over the course of early neurogenesis.

Large-scale efforts have characterized spatial gene expression in RNA *in situ* hybridization screens ([@DEV175265C49]; [@DEV175265C23]; [@DEV175265C50]; [@DEV175265C31]; [@DEV175265C57]), but such efforts are qualitative rather than quantitative and largely exclude lncRNAs. In contrast, efforts to determine global transcriptome dynamics in the developing *Drosophila* embryo ([@DEV175265C18]; [@DEV175265C8]; [@DEV175265C58]; [@DEV175265C10]) may detect the expression of lncRNAs, but lack cell type resolution. As for most complex tissues, recapitulating early neurogenesis in cell culture is unfortunately not an option, because accurate specification and differentiation of cells depends on embryonic context, intricate interactions among cells within the neuroectoderm ([@DEV175265C27]; [@DEV175265C28]) and signaling gradients involving surrounding tissues ([@DEV175265C3]; [@DEV175265C41]).

To overcome these limitations and to dissect stage- and cell type-specific transcriptomes in early neurogenesis, we adapted MARIS ([@DEV175265C22]) for use in developing *Drosophila* embryos. DIV-MARIS (*Drosophila in vivo* method for analyzing RNA following intracellular sorting) allows purification of chemically cross-linked cell types from staged developing embryos based on marker gene expression, followed by RNA extraction and next-generation sequencing. Here, we employ DIV-MARIS to determine the transcriptome dynamics in distinct neurogenic cell populations. We assess the gene expression programs of two principal neurogenic domains (the ventral and the intermediate columns) and of three differentiating cell types (neuroblasts, neurons and glia) at consecutive time points from primordial specification and subdivision to terminal differentiation.

DIV-MARIS reveals an extensive network of dynamic spatiotemporal gene expression during embryonic nervous system development. Our method reliably identifies known cell type-specific markers, but also reveals novel expression features. Furthermore, we uncover many genes -- most of which have conserved homologs in human -- that are expressed in distinct cell types throughout early neurogenesis and for which the functions remain to be elucidated. Hence, DIV-MARIS provides an accurate expression map of spatiotemporal transcriptional programs driving early nervous system development. Moreover, our analyses identified many lncRNAs expressed in cell type-specific patterns and for which no functional roles are yet known. Applying stringent criteria for selection, we characterize 13 neural cell type-enriched lncRNAs with varied temporal expression, abundance and subcellular localization. *In situ* visualization of lncRNA expression exposes an additional layer of specificity as neuroglial lncRNAs tend to be expressed highly, but only in extremely distinct subpopulations.

This study delivers a genome-wide, yet cell type-specific, view of gene expression during *Drosophila* neurogenesis from neurogenic columns to differentiated neurons and glia, provides insights into the expression properties of the coding and noncoding transcriptomes and will serve as a valuable tool for understanding how regulated coding and noncoding gene expression drives cell fate determination in early neurogenesis.

RESULTS {#s2}
=======

Isolation of neuroglial cell types with spatiotemporal resolution {#s2a}
-----------------------------------------------------------------

Early *Drosophila* neurogenesis starts with the specification of the lateral neurogenic ectoderm at the onset of zygotic transcription. The neurogenic ectoderm is quickly subdivided into distinct neurogenic columns ([@DEV175265C52]; [@DEV175265C12]), from which neuroblasts delaminate and undergo asymmetric division giving rise to ganglion mother cells (GMCs), followed by differentiation of GMCs into neurons and glia ([Fig. 1](#DEV175265F1){ref-type="fig"}A). To dissect the genome-wide transcriptional programs driving early neurogenesis, we purified specific cell populations comprising the neuroglial lineages using fluorescence-activated cell sorting (FACS) of chemically fixed cells. We isolated cells of the intermediate column (IC) and the ventral column (VC) using transgenic constructs by fusing IC- or VC-specific enhancers to reporter genes ([Fig. S1A](Fig. S1A)). Neuroblasts/GMCs, neurons and glia cells were purified using antibodies directed against the endogenous markers *prospero* (*pros*), *embryonic lethal abnormal vision* (*elav*) and *reversed polarity* (*repo*), respectively ([Fig. 1](#DEV175265F1){ref-type="fig"}D, [Fig. S1B](Fig. S1B)). Early neurogenesis is a rapidly unfolding process, with naïve primordia developing into differentiated cell types in a matter of hours ([Fig. S2A](Fig. S2A)). To assess the temporal dynamics of early neurogenesis, we collected these cell populations at developmental stages (bins) that encompass crucial events along the neurogenic lineages from early specification to terminal differentiation ([Fig. 1](#DEV175265F1){ref-type="fig"}B, [Fig. S2A](Fig. S2A)). Timed embryo collections were manually staged to confirm which neurogenic events were captured within the collection bins ([Fig. S2B](Fig. S2B)). The earliest collection bin (4-6 h after egg laying, AEL) primarily contains embryos immediately after specification and subdivision of the neurogenic ectoderm and encompasses the first rounds of neuroblast delamination. The second bin (6-8 h AEL) includes all waves of neuroblast delamination, proliferation and diversification, followed by early differentiation in the third bin (8-10 h AEL). A later collection towards the end of embryogenesis (18-22 h AEL) serves as a reference point for fully differentiated neurons and glia. Fig. 1.**DIV-MARIS for the enrichment of staged neurogenic cell types.** (A) Biological materials studied over the course of neurogenesis: intermediate column (IC); ventral column (VC); neuroblasts (NBs); neurons; glia. (B) Time windows (collection bins) of sorted materials. (C) Overview of the DIV*-*MARIS protocol. (D) Merge (right) of antibody (left) and RNA-FISH (middle) shows that the sorting strategy faithfully marks cell types of interest (NBs, Pros; neurons, Elav; glia, Repo); embryos at 6-8 h. (E) Expression of marker genes specific to the cell type of interest measured by qPCR in marker-enriched (M+), and marker-depleted (M−) populations, calculated relative to whole embryo (WE, dashed red line); embryos collected at 4-10 h AEL. Error bars represent s.e.m. Embryos are ∼500 µm in length, shown anterior leftwards and ventral downwards; stage 10/11.

To isolate cell type-specific RNA from specific neurogenic cell types, we adapted the MARIS protocol ([@DEV175265C22]), but had to introduce several modifications to temporally resolve cell types from complex and quickly developing *Drosophila* embryos *in vivo*. DIV-MARIS (outlined in [Fig. 1](#DEV175265F1){ref-type="fig"}C) is a flexible method for the isolation of high-quality RNA from specific fixed cell types within complex and rapidly developing embryos. Briefly, staged embryos are collected, dissociated into single-cell suspensions, and immediately cross-linked with formaldehyde. Neurogenic cell types were stained using antibodies, either against transgenic reporters (for the ventral and intermediate columns; [Fig. S1A](Fig. S1A)), or against endogenous markers (for neuroblasts/GMCs, neurons and glia; [Fig. 1](#DEV175265F1){ref-type="fig"}D, [Fig. S2B](Fig. S2B)). Positively marked and unmarked populations were purified by FACS ([Fig. 1](#DEV175265F1){ref-type="fig"}C). We used microscopy (e.g. [Fig. S1C](Fig. S1C)) and analytical cytometry (e.g. [Fig. S3](Fig. S3)) to confirm that the sorting strategy reliably isolated marked cells of interest; samples generally had purities \>95% and samples below 90% purity were discarded. Furthermore, we evaluated the enrichment of DIV-MARIS-sorted cell types by quantitative RT-PCR against several marker genes associated with the cell types of interest (i.e. *pros* and *worniu* in neuroblasts/GMCs, *elav* and *Lim3* in neurons, *repo* and *gcm* in glia) as independent measures of cell-type enrichment ([Fig. 1](#DEV175265F1){ref-type="fig"}E). We confirmed specific enrichment of the expected markers in sorted cells compared with whole embryos, as well as their depletion in sorted marker-negative cells.

As DIV-MARIS robustly isolates neurogenic cell populations of interest, we extracted RNA from sorted populations at four developmental time points for whole-transcriptome sequencing. Principal component analysis demonstrated that variance between samples is primarily due to developmental time and cell type of origin ([Fig. S4](Fig. S4)). The resulting cell type-specific gene expression atlas quantitatively assesses neurogenic transcription in five distinct neurogenic cell populations (enriched and depleted) across four developmental time points covering major neurogenic events ([Fig. 1](#DEV175265F1){ref-type="fig"}A,B).

Cell type-specific expression of protein-coding genes during neurogenesis {#s2b}
-------------------------------------------------------------------------

In addition to purity, we evaluated sorting specificity by assessing gene expression of the five cell type marker genes (*ind*, *vnd*, *pros*, *elav* and *repo*) across the sorted populations in terms of normalized counts ([Table S1](Table S1)). In all cases, strong enrichment of marker gene expression levels in the marker-enriched compared with the depleted samples was observed, as expected ([Fig. 2](#DEV175265F2){ref-type="fig"}A, [Fig. S5](Fig. S5)). For example, the high and near-exclusive enrichment of *repo* transcript in purified glia demonstrates sorting effectiveness of DIV-MARIS when using a highly specific and exclusive marker ([Fig. 2](#DEV175265F2){ref-type="fig"}A, [Fig. S5E](Fig. S5E)). Similarly, *elav* transcript levels were highly enriched in purified neurons compared with glia ([Fig. 2](#DEV175265F2){ref-type="fig"}A, [Fig. S5D](Fig. S5D)), whereas lower levels were detected in early neuroblasts and columnar material, which is in line with observations that the common neuronal marker *elav* is transiently expressed pan-neurogenically at the onset of differentiation ([@DEV175265C2]). The columnar markers *vnd* and *ind* mark distinct columnar neurogenic territories that each give rise to neuroblasts, neurons and glia. Accordingly, although *vnd* and *ind* transcripts were largely exclusive to their respective neurogenic columns, each was detectable to some degree in neuroblasts, most likely because early neuroblasts stem from one of the respective neurogenic columns co-purified by FACS ([Fig. 2](#DEV175265F2){ref-type="fig"}A, [Fig. S5A-C](Fig. S5A-C)). Interestingly, normalized counts for *vnd* were higher than those for *ind*, which likely reflects the fact that the ventral column generates more neuroblasts in the first waves of delamination compared with the intermediate column ([@DEV175265C15]). Fig. 2.**Defining mRNA signatures of neuroglial cell types.** (A) Normalized expression values for each marker gene used for FACS (*ind*, *vnd*, *pros*, *elav* and *repo*) across sorted samples. Error bars represent s.e.m. (B) Heat map of expression profiles of *Drosophila* nervous system genes. Row mean-centered expression values calculated by variance-stabilizing transformation (VST) of gene-level RNA-seq counts (scale=log~2~ ratio of row mean).

To validate cell type-specific gene expression, we examined genes with known neurogenic roles ([@DEV175265C52]; [@DEV175265C46]; [@DEV175265C48]; [@DEV175265C13]; [@DEV175265C42]) and confirmed specificity of mRNA expression in cell types previously associated with gene function ([Fig. 2](#DEV175265F2){ref-type="fig"}B). *exex*, for example, is a homeodomain transcription factor required in motor neurons that project to ventral somatic muscles ([@DEV175265C43]) and we found it exclusively in young neurons ([Fig. 2](#DEV175265F2){ref-type="fig"}B). Whereas markers of neuroblast identity were not only enriched in neuroblasts, but also depleted in the differentiated cell types neuroblasts give rise to (neuronal and especially glial), neurogenic column marker expression was often maintained in neuroblasts, highlighting that neuroblasts retain columnar identity after delamination, as they adopt column-specific fates ([@DEV175265C15]).

To systematically uncover protein-coding genes that demarcate columnar and cell-type identities in nervous system development, we looked for genes expressed in a similar pattern to known neurogenic genes by Pearson correlation (*r*\>0.9). We uncovered 753 additional genes (summarized in [Table S2](Table S2)) and though many have no known association with embryonic neurogenesis, *in situ* screens annotating expression using controlled anatomical imaging vocabulary (ImaGO; [@DEV175265C19]; [@DEV175265C49], [@DEV175265C50]) indicate that this gene set is indeed specifically expressed in components of the developing nervous system. For example, the most enriched ImaGO terms for this gene set include 'ventral nerve cord primordium', 'brain primordium' and 'ventral nerve cord' ([Fig. S6A](Fig. S6A)). GO analysis revealed the most enriched molecular function for this gene set to be 'DNA binding', and the most enriched biological processes were 'chromosome organization' and 'nucleic acid metabolic process' ([Fig. S6B,C](Fig. S6B,C)). Furthermore, protein domains enriched among the proteins specifically expressed in compartments of the developing nervous system included histone folds, chromatin interaction domains and sequence-specific DNA-interaction domains, such as zinc fingers and homeobox domains ([Fig. S6D](Fig. S6D)).

We were surprised that one-quarter of the genes deployed similarly to known neurogenic marker genes remain largely unstudied (199 'computed genes') and though many of these candidates lack any described function, more than 62% can be directly mapped to human homologs and some have even been linked to nervous system function.

We focused on a subset (40) of these genes, which were predicted to be expressed in neuroglial cell types with clear spatiotemporal specificity ([Fig. S7A](Fig. S7A)). In concordance with DIV-MARIS predictions, RNA *in situ* hybridization data ([@DEV175265C19]; [@DEV175265C49], [@DEV175265C50]) confirmed that a selection of these candidate genes mark specific subsets of cells in the developing nervous system ([Fig. S7B](Fig. S7B)).

Thus, DIV-MARIS reliably captures and uncovers cell type-specific gene expression dynamics during embryogenesis. As many of the specifically expressed genes encode known and predicted transcription factors and signaling pathway components ([Table S2](Table S2)), this cell type-specific expression map identifies new regulatory nodes that likely play central roles in the specification and differentiation of neuroglial cell types.

Specific expression and properties of long noncoding RNAs along the neuroglial lineage {#s2c}
--------------------------------------------------------------------------------------

To explore lncRNA expression during early neurogenesis, we first identified nervous system-specific lncRNAs by calculating enrichment of expression in marker-positive versus marker-depleted samples at each time point using DESeq2 ([@DEV175265C35]; log~2~FC\>1.0, *Padj*\<0.05). We found 325 such lncRNA candidates ([Table S3](Table S3)) and evaluated them according to several criteria, including spatiotemporal regulation through neurogenesis, expression above an abundance threshold \[transcript counts per million reads (TPM)\>300\] in at least one cell type, absence of sense overlap with a protein-coding gene, and transcript boundaries consistent with lncRNA annotations. Applying these stringent criteria, we selected 13 high-confidence lncRNA candidates that are strongly and specifically expressed in a variety of cell types of the *Drosophila* nervous system ([Fig. 3](#DEV175265F3){ref-type="fig"}, [Fig. S8](Fig. S8)). Fig. 3.**Neuroglial lncRNAs are highly regulated transcripts.** (A) Row mean-centered expression values of lncRNAs in marker-enriched and -depleted samples (scale=log2 ratio of row mean, gene level VST). (B) PhyloCSF scores (ScorePerCodon) for the putative ORF with the highest coding potential within each transcript. Scale is from ∼1 s.d. above the mean score of coding regions (very high coding potential) down to ∼1 s.d. below the mean of noncoding regions (very low coding potential). (C) Row mean-centered expression profiles in 6-8 h and 18-22 h embryo nuclear and cytoplasmic fractions generated by Fractionation-Seq; values as in A. (D) Violin plot showing distribution of maximum TPM (maxTPM) values for all lncRNAs (red; *n*=325) and mRNAs (gray; *n*=3835) differentially expressed (log~2~FC\>1.0, *Padj*\<0.05) between any marker-positive and marker-negative cell type; lncRNAs presented in A are highlighted. (E) *CR30009* genomic locus showing stranded RNA-seq data from sorted glia at 6-8 h AEL (negative strand; blue), overlay of smoothed PhyloCSF scores of individual codons in each of three frames (horizontal line is 0), and conservation among drosophilids (phastCons).

To assess spatiotemporal expression of these lncRNAs, we calculated their relative abundance among all cell types and collection bins. The lncRNAs were depleted in marker-negative non-neurogenic cells and exhibited dynamic spatiotemporal enrichment in specific marker-positive cell types ([Fig. 3](#DEV175265F3){ref-type="fig"}A). Strikingly, although we found very few lncRNAs with distinct expression in the earlier and more naïve intermediate and ventral columns, specific lncRNA deployment could be readily observed in more mature and differentiated cell types, such as neuroblasts, neurons and/or glia, indicating that lncRNA expression is a hallmark of differentiated cells more so than of primordia.

To confirm that these transcripts are bona fide lncRNAs, we evaluated the coding potential of each by phylogenetic codon substitution frequency (PhyloCSF) ([@DEV175265C33]). Each lncRNA locus exhibited a total PhyloCSF score below zero across all frames, consistent with a complete lack of coding potential ([Fig. 3](#DEV175265F3){ref-type="fig"}B). Given that some lncRNAs have been shown to exhibit variable subcellular localization with localized functions ([@DEV175265C11]), we assessed the general subcellular expression of these transcripts by Fractionation-Seq. Briefly, we generated a subcellular reference transcriptome of the cytoplasmic and nuclear compartments of 6-8 h and 18-22 h embryos and examined abundance of each of these lncRNA transcripts between these fractions. Intriguingly, the 13 lncRNAs exhibited distinct subcellular localization patterns with varying degrees of nuclear/cytoplasmic restriction ([Fig. 3](#DEV175265F3){ref-type="fig"}C), ranging from almost exclusively cytoplasmic (e.g. *CR30009* and *cherub*) to almost exclusively nuclear (e.g. *CR45312*) detection, including instances in which location appeared to be temporally regulated (e.g. *CR44978*).

To assess lncRNA abundance relative to other transcripts (noncoding and protein-coding) in the neurogenic cell types, we normalized read counts for each transcript in each sample (TPM, [Table S4](Table S4)). The maximum expression score for lncRNAs across cell types (maxTPM) showed that although expression varies among lncRNAs, they are generally not expressed at low levels; rather, lncRNA expression was well within the range of what may be expected for protein-coding genes significantly regulated during neurogenesis ([Fig. 3](#DEV175265F3){ref-type="fig"}D). That these lncRNAs are bona fide regulated transcripts is further supported by specific splicing, which was observed for several of the neurogenic lncRNAs ([Fig. 3](#DEV175265F3){ref-type="fig"}E, [Fig. S8](Fig. S8)). Thus, these lncRNAs are unlikely to be merely by-products of spurious transcription; rather, they are subject to regulated expression, RNA processing, and controlled export, which supports a potential role in neurogenesis.

One intriguing example of a lncRNA demonstrating specific expression over the course of early neurogenesis is *CR30009*. This lncRNA showed increased expression in the early intermediate column and in neuroblasts, but was most highly enriched in glial cells during all assayed time windows ([Fig. 3](#DEV175265F3){ref-type="fig"}A). Furthermore, *CR30009* is spliced and primarily exported to the cytoplasm ([Fig. 3](#DEV175265F3){ref-type="fig"}C,E), features indicative of specific co- and post-transcriptional regulation. However, *CR30009* has the lowest coding potential out of all tested lncRNAs: its PhyloCSF score per codon (−42.647) was more than three standard deviations below the mean for noncoding regions in *Drosophila* (−18.7±7.2, [Fig. 3](#DEV175265F3){ref-type="fig"}B). Furthermore, *CR30009* is one of the most highly abundant transcripts in glia -- noncoding or protein-coding (log~2~ maxTPM=15.75, [Fig. 3](#DEV175265F3){ref-type="fig"}D, [Table S3](Table S3)) -- which underscores the potential functional importance of *CR30009* in gliogenesis. Notably, this lncRNA appears to exist predominantly as an unannotated short isoform and exhibits regions of high noncoding sequence conservation among drosophilids within the first exon and at the 3′ end of the transcript ([Fig. 3](#DEV175265F3){ref-type="fig"}E).

A second example, *CR43283* (also known as *cherub*), exhibited dynamic temporal regulation. Expression of *cherub* was strongly enriched in the earliest neuroblasts at 4-6 h, but enrichment quickly waned in later neuroblasts (6-8 h); however, over time *cherub* became specifically expressed being strongly enriched in differentiated neurons and glia by the end of neurogenesis at 18-22 h AEL ([Fig. 3](#DEV175265F3){ref-type="fig"}A). We note that enriched expression of the lncRNA in Elav- and Repo-negative samples may be caused by *cherub*-positive glia in the neuron-depleted fraction and *cherub*-positive neuroblasts/neurons in the glia-depleted fraction. *cherub* was also specifically localized to the cytoplasm throughout embryogenesis and is clearly spliced, but harbors no coding potential ([Fig. 3](#DEV175265F3){ref-type="fig"}B,C, [Fig. S8D](Fig. S8D)).

*CR32730* was first detected in 4-6 h neuroblasts and was moderately enriched at 8-10 h in the neuronal, but not in the glial, population ([Fig. 3](#DEV175265F3){ref-type="fig"}A). *CR32730* is transcribed antisense to the intron of *CG9650* ([Fig. S8C](Fig. S8C)), a putative neurogenic transcription factor that has been implicated in CNS development ([@DEV175265C36]). However, *CR32730* appears to be transcribed independently of *CG9650*, which was expressed at low levels in early neuroblasts according to DIV-MARIS ([Fig. S8C](Fig. S8C)), suggesting that their roles could be independent. Fractionation-Seq predicts that *CR32730* is moderately enriched in the nuclear fraction in early and late embryos ([Fig. 3](#DEV175265F3){ref-type="fig"}C).

Expression of another lncRNA, *CR46003*, was first detected in the ventral column and was most highly enriched in early neuroblasts, but expression persisted in neuroblasts and early neurons ([Fig. 3](#DEV175265F3){ref-type="fig"}A). *CR46003* was one of the most abundant lncRNAs in our dataset and did not exhibit clear subcellular enrichment in either early or late embryos ([Fig. 3](#DEV175265F3){ref-type="fig"}C,D). Intriguingly, the transcription start site of *CR46003* is antisense to *CR46004*, which contains a miRNA implicated in behavior ([@DEV175265C38]) ([Fig. S8B](Fig. S8B)).

*CR44024* expression was first enriched in early neuroblasts and persisted through neuronal differentiation, and is predicted to be excluded from the intermediate and ventral columns and glia ([Fig. 3](#DEV175265F3){ref-type="fig"}A). This lncRNA is not predicted to exhibit distinct subcellular localization in early (6-8 h) embryos, but was moderately enriched in the cytoplasm at the end of embryogenesis (18-22 h, [Fig. 3](#DEV175265F3){ref-type="fig"}C). *CR44024* was also one of the highly expressed lncRNAs in our dataset with expression on a par with protein-coding genes ([Fig. 3](#DEV175265F3){ref-type="fig"}D). The transcript is intergenic, and appears to be spliced, although not in accordance with its annotated transcript model ([Fig. S8E](Fig. S8E)).

In summary, DIV-MARIS predicted spatiotemporal expression of a number of lncRNAs during neurogenesis. Through the application of stringent criteria, we refined this list to a high-confidence selection of noncoding transcripts with diverse predicted expression patterns and properties. To confirm these predictions for several lncRNA candidates, we first visualized their expression in the context of a whole developing embryo.

Neurogenic lncRNAs mark specific neuroglial subsets {#s2d}
---------------------------------------------------

To visualize lncRNA expression, we performed multiplex RNA fluorescent *in situ* hybridization (RNA-FISH; [@DEV175265C26]) against the five examples discussed above (*CR30009*, *cherub*, *CR46003*, *CR32730* and *CR44024*) together with neurogenic marker genes. Remarkably, RNA-FISH revealed exquisite spatiotemporal specificity of lncRNA expression for each of the lncRNAs tested.

*CR30009* -- predicted by DIV-MARIS to be highly enriched in glia -- was indeed co-expressed with *repo* as expected in clusters of glial cells as early as stage 9/10 ([Fig. 4](#DEV175265F4){ref-type="fig"}A,B, [Fig. S9](Fig. S9)). *CR30009* remained co-expressed with most *repo*-expressing cells through stage 13/14 ([Fig. 4](#DEV175265F4){ref-type="fig"}C,D). However, timing of *CR30009* expression suggests it to be independent of *repo*, indicating that this lncRNA constitutes an earlier marker of the glial lineage than currently known*.* Although most *repo*-positive cells also expressed *CR30009* in stage 9-12 embryos, the lncRNA was largely expressed in small puncta within other cells in the ventral nerve cord and brain that are likely to be neuroblasts ([Fig. 4](#DEV175265F4){ref-type="fig"}A,B, [Fig. S9](Fig. S9)). Accordingly, DIV-MARIS predicts *CR30009* expression in 4-6 h and 6-8 h *pros*-positive cells ([Fig. 3](#DEV175265F3){ref-type="fig"}A, [Fig. S10](Fig. S10)). It is feasible, therefore, that the lncRNA *CR30009* constitutes the earliest neuroblast marker of the glial lineage identified to date, which accumulates into larger, brighter foci during early phases of glial differentiation ([Figs S9, S10](Figs S9, S10)). Fig. 4.**The lncRNA *CR30009* is expressed in glial subsets.** RNA-FISH against *CR30009* and the glial marker *repo*. (A) Lateral view, stage 11/12. (B) Ventral view, stage 11/12. (C) Lateral view, stage 13. (D) Ventral view; stage 13/14. Top: *CR30009* alone; below: merge of *CR30009* (magenta) with *repo* (green). Second from bottom: enlargement of the region of interest (ROI) indicated by the dotted white box. Bottom: Slice through *z*-stack at the level indicated by the yellow line. Embryos are ∼500 µm along the long axis, oriented anterior leftwards and ventral downwards in lateral views.

RNA-FISH against the lncRNA *cherub* revealed strong spatiotemporal regulation of *cherub* broadly in accordance with DIV-MARIS, which predicted *cherub* to be strongly and specifically enriched in early (4-6 h) neuroblasts, and late (18-22 h) neurons and glia ([Fig. 3](#DEV175265F3){ref-type="fig"}A). We observed clear induction of *cherub* expression within six small clusters of cells in the ventral nerve cord during stage 12, each of which also expressed *pros* ([Fig. 5](#DEV175265F5){ref-type="fig"}A) and to a lesser degree, *elav* ([Fig. 5](#DEV175265F5){ref-type="fig"}B); both of these observations are in line with *cherub* constituting a neuroblast marker. During stage 13, *cherub* was seen in several additional clusters in the brain ([Fig. 5](#DEV175265F5){ref-type="fig"}B, [Fig. S11A,B](Fig. S11A,B)). By stage 14-15, *cherub* was very strongly expressed in multiple defined *pros* neuroblast clusters, but appeared to be excluded from mature neurons and glia ([Fig. 5](#DEV175265F5){ref-type="fig"}C,D, [Figs S11C,D, S12](Figs S11C,D, S12)), and remained strongly expressed through the remainder of embryogenesis (stage 16/17, [Fig. S12B](Fig. S12B)), in line with DIV-MARIS predictions ([Fig. 3](#DEV175265F3){ref-type="fig"}A). Fig. 5.**The lncRNA *cherub* is expressed with strict spatiotemporal specificity primarily in a subset of neuroblasts.** RNA-FISH against *cherub*, the neuroblast marker *pros* and the neuronal marker *elav*. Ventral views. (A) *cherub* with *pros*; stage 12. (B) *cherub* with *elav*; stage 13. (C) *cherub* with *pros*; stage 15. (D) *cherub* with *elav*; stage 14. Top: *cherub* alone. Second from top: *cherub* (magenta) overlaid with marker (green). Second from bottom: enlargement of the region of interest (ROI) indicated by the dotted white box. Bottom: Slice through *z*-stack at the level indicated by the yellow line. Embryos are ∼500 µm along the long-axis, oriented anterior leftwards.

DIV-MARIS predicts similar spatiotemporal expression of *CR46003* and *CR32730* in neuroblasts and neurons ([Fig. 3](#DEV175265F3){ref-type="fig"}A). Indeed, RNA-FISH revealed very similar patterns of expression of the two lncRNAs. *CR46003* exhibited the earliest expression of all lncRNAs tested here and is was in a small cell cluster already at stage 5-6 ([Fig. S13](Fig. S13)). By stage 9-10, punctate expression of *CR46003* appeared in defined *pros-*expressing clusters along the embryonic ventral midline ([Fig. 6](#DEV175265F6){ref-type="fig"}A), in agreement with the DIV-MARIS-predicted enrichment in cells of the ventral column and neuroblasts at 4-6 and 6-8 h AEL ([Fig. 3](#DEV175265F3){ref-type="fig"}A). *CR46003* expression expanded to a greater number of cells within and beyond the ventral nerve cord and brain from stage 11-13, many of which also expressed *pros* ([Fig. 6](#DEV175265F6){ref-type="fig"}B, [Fig. S14A-C](Fig. S14A-C)) and some expressed *elav* as well ([Fig. S15](Fig. S15)). As predicted by DIV-MARIS, RNA-FISH demonstrated that *CR32730* follows a very similar pattern of expression to *CR46003* from stage 9-10 to stage 13 ([Fig. 6](#DEV175265F6){ref-type="fig"}, [Fig. S14](Fig. S14)). Fig. 6.**The lncRNAs *CR46003* and *CR32730* are expressed with similar spatiotemporal specificity in a subset of neuroblasts.** RNA-FISH against *CR46003* and *CR32730* together with the neuroblast marker *pros*. Ventral views. (A) *CR46003*; stage 9. (B) *CR46003*; stage 11/12. (C) *CR32730*; stage 10. (D) *CR32730*; stage 11/12. Top: lncRNA alone. Second from top: lncRNA (magenta) overlaid with *pros* (green). Second from bottom: enlargement of the region of interest (ROI) indicated by the dotted white box. Bottom: Slice through *z*-stack at the level indicated by the yellow line. Embryos are ∼500 µm along the long axis, oriented anterior leftwards.

Although we were not able to detect the transient *CR44024* expression in early (stage 9-10) *pros*-positive neuroblasts as predicted by DIV-MARIS, we did observe that this lncRNA exhibits highly dynamic temporal regulation. At stage 12, *CR44024* was induced within small *elav*-positive clusters flanking the midline ([Fig. S16](Fig. S16)). Starting at stage 13, *CR44024* was expressed much more broadly, yet was still restricted to subsets of *elav-* and *pros-*expressing cells within the ventral nerve cord and central brain ([Fig. 7](#DEV175265F7){ref-type="fig"}). Fig. 7.**The lncRNA *CR44024* is expressed later in embryogenesis in neuronal subsets.** RNA-FISH against *CR44024*, the neuroblast marker *pros* and the neuronal marker *elav*. (A) *CR44024* and *elav*; lateral view; stage 13. (B) *CR44024* and *pros*; lateral view; stage 13. (C) CR44024 and *elav*; ventral view; stage 14. (D) *CR44024* and *pros*; ventral view; stage 14. Top: *CR44024* alone. Second from top: *CR44024* (magenta) overlaid with marker (green). Second from bottom: enlargement of the region of interest (ROI) indicated by the dotted white box. Bottom: Slice through *z*-stack at the level indicated by the yellow line. Embryos are ∼500 µm along the long axis, oriented anterior leftwards and ventral downwards in lateral views.

Lastly, we assessed the subcellular localization of individual lncRNAs. For example, Fractionation-Seq ([Fig. 3](#DEV175265F3){ref-type="fig"}C) predicted *CR30009* and *cherub* to be predominantly cytoplasmic. This is supported for both lncRNAs by high-resolution confocal microscopy, as both transcripts were primarily detected in the cytoplasm ([Fig. S17A,B](Fig. S17A,B)). *CR46003* and *CR32730* both showed a slight bias for nuclear localization by Fractionation-Seq, which was confirmed by microscopy as both lncRNAs were clearly stained within the nucleus, though it should be noted that subnuclear puncta were observed ([Fig. S17C,D](Fig. S17C,D)). Similarly, *CR44024* appeared to be restricted primarily to the nucleus in the ventral nerve cord at stage 14 ([Fig. S17E](Fig. S17E)), matching the prediction.

The identification of such complex, yet specific, expression patterns highlights the importance of tissue- and cell type-specific expression analysis. Whole embryo studies, for example, not only lack spatial resolution, but expression signatures -- even of highly expressed genes -- may be lost if their expression is specific to a small-enough subset of cells. Here, we provide a map for the cell type-specific expression of coding, as well as noncoding, RNAs over the course of embryonic neurogenesis in the developing *Drosophila* embryo. Although hundreds of coding and dozens of lncRNAs are deployed with specific spatial and temporal dynamics, it should be noted that direct imaging of expression within a spatial context can reveal nuances of expression that is beyond the resolution of many cell type-specific genomic approaches.

DISCUSSION {#s3}
==========

Complex tissues are defined by the intricate interplay of individual cell types that differ in their gene expression programs. Tissue culture has long been an important tool for the genome-wide investigation of cellular responses as it avoids much of the heterogeneity inherent to living tissues. Unfortunately, it is often precisely this heterogeneity and the dynamic contacts between cells and tissues that shape cellular identities and transcriptomic responses. Hence, to determine the gene regulatory programs that drive complex organismal development, it is crucial to (1) preserve the cellular interactions *in vivo*, (2) acquire genome-wide transcriptomic data with spatial and/or cell-type resolution, and (3) assure temporal resolution.

DIV-MARIS to investigate global cell type-specific gene expression dynamics {#s3a}
---------------------------------------------------------------------------

To investigate the transcriptome dynamics over the course of neurogenesis from primordial to neuronal and glial identities, we developed a method of isolating specific cell types from *Drosophila* embryos with resolution in time and space. DIV-MARIS is widely applicable and can be employed for spatiotemporal transcriptional profiling of basically any cell type of interest in the *Drosophila* embryo and other complex tissues, as long as markers allowing for sorting a cell type of interest are available (i.e. appropriate antibodies or transgenic markers e.g. enhancer-reporter constructs). DIV-MARIS employs chemical cross-linking of the cellular material, thus ensuring that the developmental status quo is preserved, and elaborate sorting strategies based on multiple markers, which could be devised to fine-tune the sub-population selection one wishes to purify ([@DEV175265C37]).

Here, we purified fixed cells based on markers of specific neurogenic cell populations in the early *Drosophila* embryo. DIV-MARIS faithfully resolved known expression patterns of neurogenic protein-coding genes, but also identified cell type-specific expression of additional genes with yet unknown neurogenic functions; neuroglial expression was confirmed by *in situ* hybridization for a few dozen mRNAs, but hundreds more are predicted to exhibit spatiotemporal expression over the course of early neurogenesis. This compendium lays the groundwork for a comprehensive understanding of the mechanisms driving early neurogenesis and, given that many of the spatiotemporally expressed genes encode regulatory factors such as transcription factors and signaling molecules, careful examination of their neurogenic roles will be required.

Identification of spatiotemporal lncRNA expression {#s3b}
--------------------------------------------------

This study has identified many cell type-specific lncRNAs with potential neurogenic function. We emphasize that this is not yet an exhaustive list of lncRNAs expressed in the nervous system, as our filtering criteria were conservative. Instead, we focused on a high-confidence set of 13 lncRNAs with a variety of expression and transcript characteristics. Given that these noncoding transcripts are (1) temporally expressed in specialized cell types and subtypes of the nervous system, (2) moderately-to-highly abundant and (3) often exhibit hallmarks of RNA processing (such as splicing and nuclear-cytoplasmic shuttling), these lncRNAs appear to be subject to regulated expression rather than being by-products of spurious transcription.

Notably, we did not identify any lncRNAs with expression restricted to the early neuroectodermal columns. According to DIV-MARIS, there is some enrichment of *CR30009* in the intermediate column and *CR46003* in the ventral column ([Fig. 3](#DEV175265F3){ref-type="fig"}A), but as the respective territorial markers of the ventral and intermediate columns are still detectable in the neuroblast progenitors, this expression may be specific to neuroblasts, in which higher enrichment is observed. High and specific lncRNA expression appears to be a feature of differentiating and differentiated cell types of the nervous system, rather than of primordial territories.

Multiplex RNA-FISH shows that lncRNAs often exhibit a high degree of cell-type specificity. Though co-expression was generally detected with cell type-specific markers, as predicted by DIV-MARIS, we could observe much more nuanced spatiotemporal lncRNA regulation than we could have predicted -- the noncoding transcripts investigated here tended to be expressed in highly specific subsets of neurogenic cell types ([Figs 4](#DEV175265F4){ref-type="fig"}--[7](#DEV175265F7){ref-type="fig"}). It is therefore feasible that these lncRNAs perform highly specialized functions in subsets of cells contributing to discrete regions of the nervous system.

For example, *CR46003* and *CR32730* are the first lncRNAs that appear to specifically mark midline and midline-proximal structures ([Fig. 6](#DEV175265F6){ref-type="fig"}, [Fig. S14](Fig. S14)). Given the midline\'s highly specialized role as a signaling and organizing center ([@DEV175265C55]; [@DEV175265C13]; [@DEV175265C59]), it is intriguing to speculate that such lncRNAs may help shape the midline fates. Although lncRNAs were enriched in a variety of neurogenic populations, *CR30009* was consistently and highly enriched in *repo-*positive glia and to some degree in *pros*-expressing neuroblasts ([Fig. 4](#DEV175265F4){ref-type="fig"}, [Figs S9, S10](Figs S9, S10)). It is feasible that *CR30009* may play a role in the priming of glial fates from the earliest stages of differentiation, possibly mediating the transition from neuroblasts and GMCs to specifically the glial fate. As most glia in the *Drosophila* embryonic CNS originate from the lateral column, it will be of interest to determine whether *CR30009* expression and function are limited to glia of the lateral neurogenic ectoderm, or present in ventral column-derived glia as well.

Are these lncRNAs functional? *cherub* serves as a nice example arguing that several of them likely are. The lncRNA *cherub* was recently identified as a highly upregulated transcript in neuroblast-derived tumors in larvae ([@DEV175265C30]). In larvae, *cherub* is asymmetrically inherited by the self-renewing neuroblast to allow fate progression of the sibling cell and *cherub*'s specific predicted enrichment in embryonic neuroblasts ([Fig. 3](#DEV175265F3){ref-type="fig"}A) indicates that this lncRNA could exhibit a similar function in the early embryo. However, the precise temporal regulation of *cherub* was surprising, as RNA-FISH identified its presence not in early, but in differentiating and fully differentiated neurons and glia by the end of embryogenesis ([Fig. 5](#DEV175265F5){ref-type="fig"}, [Figs S11, S12](Figs S11, S12)).

Intricate spatiotemporal expression regulation is a hallmark of many lncRNAs ([@DEV175265C57]; [@DEV175265C24]; [@DEV175265C30]). Various lncRNAs have been demonstrated to play diverse biological roles -- nuclear and cytoplasmic -- from integral parts of riboprotein complexes, to regulating dosage compensation, to affecting genome topology. lncRNA complexity has been reported to be especially pronounced in the nervous system ([@DEV175265C6]; [@DEV175265C37]) and even early stages of embryonic neurogliogenesis appear to be no exception. However, the challenge clearly remains to unravel the neurogenic roles of these putative noncoding regulators, and the molecular mechanisms by which they act. This study represents a valuable resource for understanding transcriptome complexity in the emerging nervous system and it lays the basis for further studies into the mechanisms by which noncoding genes, but also hundreds of specifically deployed coding genes, shape nervous system development.

MATERIALS AND METHODS {#s4}
=====================

Fly lines {#s4a}
---------

For details of fly strains and husbandry, see [supplementary Materials and Methods](supplementary Materials and Methods).

FACS purification and RNA isolation using DIV-MARIS {#s4b}
---------------------------------------------------

Briefly, embryos were dissociated into single-cell suspensions, and cells were fixed in 4% formaldehyde. Fixed cell suspensions were immunostained under RNase-free conditions and FACS-purified using a FACS-AriaII cell sorter (BD Biosciences). Marker-enriched and -depleted cell populations were collected in biological duplicates. FACS-purified cells were subject to cross-link reversal and proteinase K digestion prior to RNA isolation. Additional experimental details for DIV-MARIS are provided in the [supplementary Materials and Methods](supplementary Materials and Methods); primary and secondary antibodies used in this study are listed in [Table S6](Table S6).

Nuclear-cytoplasmic fractionation {#s4c}
---------------------------------

Cytoplasmic and nuclear extracts were isolated from whole *Drosophila* embryos by detergent-based hypotonic lysis for RNA isolation. Additional experimental details are provided in the [supplementary Materials and Methods](supplementary Materials and Methods).

Quantitative RT-PCR (qPCR) {#s4d}
--------------------------

qPCR was performed using standard SYBR Green, with the Bio-Rad CFX96 Touch Real-Time PCR Detection System. Additional information is available in the [supplementary Materials and Methods](supplementary Materials and Methods); qPCR primer sequences are listed in [Table S7](Table S7).

Library preparation and RNA-sequencing {#s4e}
--------------------------------------

All RNA-seq libraries were constructed using the NuGEN Ovation *Drosophila* RNA-Seq System with 10-100 ng total RNA input. Library concentration was quantified using the Qubit dsDNA HS Assay (Thermo Fisher Scientific, Q32854) and quality was determined on a BioAnalyzer using Agilent High Sensitivity DNA Kits (Agilent, 5067-4626). All libraries were sequenced on the Illumina HiSeq4000 at a mean depth of 62.5 million 75 bp paired-end reads per sample. RNA-seq datasets generated for this study are detailed in [Tables S10](Tables S10) and [S11](S11).

Bioinformatic analysis of RNA-seq data {#s4f}
--------------------------------------

Sequencing files were demultiplexed using bcl2fastq (v2.19, Illumina), and quality determined using FastQC (<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>). A genomic reference index for *Drosophila melanogaster* was constructed with RSEM using the most recent genome build (BDGP release 6) and transcriptome annotation (Release 6.15) obtained from Flybase ([www.flybase.org](www.flybase.org)). Annotations used for lncRNAs have been described by [@DEV175265C58]. Paired-end reads were pseudo-aligned to the RSEM reference index using Salmon (Release 0.8.1) using the following parameters: \$ salmon quant \--libType ISF --seqBias --gcBias --posBias -p 8 \--numBootstraps 100.

Gene-level counts were prepared for differential expression analysis with tximport as part of the Bioconductor package (Release 3.5). Feature length-scaled TPM values were calculated with tximport using the following command: \>tximport(files, type="salmon", countsFromAbundance="lengthScaledTPM", tx2gene=tx2gene).

Given the cell-type heterogeneity between samples in this dataset, we used normalized counts instead of TPM or FPKM for more accurate inter-sample comparisons of gene abundance. We normalized gene-level counts via variance stabilizing transformation ([Table S1](Table S1)). Variance-stabilized transformed counts, principal component analysis, and differential expression were calculated using DESeq2 ([@DEV175265C35]) as part of the Bioconductor package (Release 3.5), using default parameters.

PhyloCSF {#s4g}
--------

PhyloCSF uses substitutions and codon frequencies in a genome alignment of 23 drosophilid species to distinguish the evolutionary signature of selection for protein-coding function ([@DEV175265C33]). For each transcript, PhyloCSF generates a score for the putative open reading frame (ORF) with highest coding potential; transcripts with positive scores are more likely to be protein coding. The candidate ORFs, their PhyloCSF scores, and other related information are included in [Table S5](Table S5).

Briefly, local alignments used for PhyloCSF were extracted from the 23-drosophilid subset of the 27-way MULTIZ insect whole-genome alignments ([@DEV175265C4]), downloaded from UCSC: <http://hgdownload.soe.ucsc.edu/goldenPath/dm6/multiz27way/> ([@DEV175265C51]). PhyloCSF scores were computed using the 23flies parameters with the options '-f3 \--orf=ATGStop \--allScores \--bls', which computes the score of every ORF within the transcript that begins with ATG, is followed by a stop codon, and is at least the default length of 25 codons. Because CR44272 has no putative ORFs that long, we used '\--minCodons=19' to lower the threshold for that gene to the length of its longest putative ORF. We then selected the ORF in each transcript having the highest PhyloCSF score. The reported 'ScorePerCodon' is the PhyloCSF score divided by the number of codons in the putative ORF. To identify potential cases in which one of the transcripts under consideration contains part of a coding ORF but the complete ORF is in an unidentified overlapping transcript, we also ran PhyloCSF using the \--orf=StopStop3 option, with \--minCodons=10, which looks for ORF fragments ending in a stop codon. However, that did not identify any plausible partial coding ORFs. The PhyloCSF track images in [Fig. 3](#DEV175265F3){ref-type="fig"} and [Fig. S6](Fig. S6) are overlays of the 'Smoothed PhyloCSF' tracks in all three frames on the appropriate strand, from the PhyloCSF track hub in the UCSC genome browser, documented at: <https://data.broadinstitute.org/compbio1/PhyloCSFtracks/trackHub/hub.DOC.html>.

Generation of coverage plots {#s4h}
----------------------------

The strand-specific and paired-end RNA-seq reads were mapped to the *Drosophila melanogaster* reference genome dm6 with the splicing-aware mapper STAR v2.5.3a ([@DEV175265C14]) using default parameters and a *Drosophila*-specific adjustment for maximum intron length and mate distance of 50 kb. The resulting BAM files were filtered to include only uniquely mapping read pairs and then converted into strand-specific genome coverage tracks in BigWig format for visualization in the UCSC genome browser ([@DEV175265C25]; [@DEV175265C39]) using the stranded-coverage (<https://github.com/pmenzel/stranded-coverage>) and wigToBigWig from the UCSC genome browser tools.

Immunohistochemistry and FISH {#s4i}
-----------------------------

Immunohistochemistry and RNA-FISH were performed as previously described ([@DEV175265C26]; [@DEV175265C24]). Primary and secondary antibodies used in this study are listed in [Table S6](Table S6). The procedure for probe synthesis is detailed in [supplementary Materials and Methods](supplementary Materials and Methods), and RNA probes are listed in [Tables S8](Tables S8) and [S9](S9).

Microscopy {#s4j}
----------

Confocal stacks were imaged at BIMSB/MDC using a Leica SP8 equipped with 405 nm laser diode, white light laser, and hybrid detectors, with a 20× glycerol objective. For each field of view, 65-85 slices were acquired using ∼AU=1 pinholes and taking care not to saturate signal. Appropriate slices were maximum intensity projected. Imaging work at the BioFrontiers Institute\'s Advanced Light Microscopy Core was carried out on either a Nikon A1R laser scanning confocal microscope (NIST-CU Cooperative Agreement 70NANB15H226) or on a Nikon Ti-E spinning disc confocal microscope (BioFrontiers Institute, Howard Hughes Medical Institute).
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